[Atypical agents of wound infection and targeted samples]

Nastja Kucisec-Tepes1

  • 1Croatian Academy of Medical Sciences, Zagreb, Croatia. davorin.tepes@gmail.com

Insights

Chronic wounds can harbor diverse bacterial infections, including common pathogens like Staphylococcus aureus and atypical opportunists. Accurate diagnosis requires careful sample collection, often utilizing biopsy, and collaboration with clinical microbiologists.

Area of Science:

  • Microbiology
  • Wound Care
  • Infectious Diseases

Context:

  • Open wounds are susceptible to microbial contamination and colonization, with chronic wounds presenting unique infection challenges.
  • Bacterial load, virulence factors, microbial synergy (aerobic/anaerobic), and biofilm formation significantly influence wound infection development.
  • While common pathogens like Staphylococcus aureus and Pseudomonas aeruginosa infect both acute and chronic wounds, chronic infections often involve atypical or opportunistic agents.

Purpose:

  • To differentiate between common and atypical microbial agents responsible for acute and chronic wound infections.
  • To highlight the importance of appropriate diagnostic sampling methods, emphasizing biopsy and aspirate over swabs.
  • To underscore the necessity of a meticulous diagnostic approach, including patient review and clinical microbiologist consultation, for effective treatment.

Summary:

  • Chronic wound infections involve a complex interplay of factors, including high bacterial loads, virulence, and the presence of both common and atypical pathogens.
  • Atypical agents, often opportunistic, require advanced diagnostic methods beyond standard microbiology, necessitating molecular techniques for identification.
  • Effective diagnosis hinges on appropriate sample selection (biopsy preferred), wound decontamination prior to sampling, and close collaboration between clinicians and microbiologists.

Impact:

  • Improved diagnostic accuracy for chronic wound infections, leading to more targeted and effective antimicrobial therapies.
  • Reduced incidence of treatment failure due to the identification of resistant or atypical pathogens.
  • Enhanced understanding of the microbial landscape in chronic wounds, informing future research and clinical guidelines.